SNGX – soligenix, inc. (US:NASDAQ)

News

SNGX: Phase 3 FLASH2 Trial of HyBryte in CTCL Underway… [Yahoo! Finance]
Soligenix Initiates Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma
EXCLUSIVE: Soligenix Starts Confirmatory Late-Stage Trial For HyBryte For Type Of Blood Cancer [Yahoo! Finance]
HyBryte™ Clinical Results Demonstrate Continued Improvement Post-Treatment [Yahoo! Finance]
HyBryte™ Clinical Results Demonstrate Continued Improvement Post-Treatment
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com